PATENT CLAIM ANALYSIS

Application Number: 16071981
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "081000"]

Abstract:
A method of attaining virologic suppression in a heavily treatment-experienced (HTE) individual infected with the HIV-1 virus involves administering to the individual a treatment regimen comprising the drug fostemsavir together with an optimized background therapy (OBT). This treatment regimen should maintain virologic suppression to a plasma HIV-1 RNA level of less than 200 copies (c)/mL for an extended period.

Claim (Index 4):
The method of  claim 3 , wherein said OBT comprises at least 1 other HIV drug medication.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.38776
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15749189', '15579977', '15749144', '11064683', '12132145']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7554919519930441
- 35 USC 102 Novelty (BERT): 0.5223281219711554
- Combined Prediction Score: 0.7321755689908552
- Mean Citation Score: 268.490192
- Max Citation Score: 283.46973
- Similarity Product: 188.4965123322237

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test